Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551 AND Prognosis
28 results:

  • 1. Effect of serum lactate dehydrogenase-to-albumin ratio (LAR) on the short-term outcomes and long-term prognosis of colorectal cancer after radical surgery.
    Shu XP; Xiang YC; Liu F; Cheng Y; Zhang W; Peng D
    BMC Cancer; 2023 Sep; 23(1):915. PubMed ID: 37770882
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Survival comparison of first-line treatment regimens in patients with braf-mutated advanced colorectal cancer: a multicenter retrospective study.
    Meng Q; Zhao J; Yu Y; Wang K; Ren J; Xu C; Wang Y; Wang G
    BMC Cancer; 2023 Feb; 23(1):191. PubMed ID: 36849918
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Posterior pelvic exenteration for ovarian cancer: surgical and oncological outcomes.
    Houvenaeghel G; de Nonneville A; Blache G; Buttarelli M; Jauffret C; Mokart D; Sabiani L
    J Gynecol Oncol; 2022 May; 33(3):e31. PubMed ID: 35320883
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [A Case of Isolated Metachronous Splenic Metastasis after Rectal cancer Surgery].
    Kuboyama Y; Sumi T; Sahara Y; Fukushima G; Matsumoto M; Matsudo T; Tachibana S; Mimuro H; Ishibashi Y; Katsumata K; Tsuchida A
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):1688-1690. PubMed ID: 35046298
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. DJ‑1 is a new prognostic marker and predicts chemotherapy efficacy in colorectal cancer.
    Wang W; Wang H; Xiang L; Ni T; Jin F; Deng J; Zhang Y; Shintaro I; Zhou Y; Liu Y
    Oncol Rep; 2020 Jul; 44(1):77-90. PubMed ID: 32627002
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Microarray Analysis of Gene Expression Involved in Butyrate-Resistant colorectal Carcinoma HCT116 Cells.
    Khonthun C; Saikachain N; Popluechai S; Kespechara K; Hiranyakas A; Srikummool M; Surangkul D
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1739-1746. PubMed ID: 32592372
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. SWATH-based proteomics reveals processes associated with immune evasion and metastasis in poor prognosis colorectal tumours.
    López-Sánchez LM; Jiménez-Izquierdo R; Peñarando J; Mena R; Guil-Luna S; Toledano M; Conde F; Villar C; Díaz C; Ortea I; De la Haba-Rodríguez JR; Aranda E; Rodríguez-Ariza A
    J Cell Mol Med; 2019 Dec; 23(12):8219-8232. PubMed ID: 31560832
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. CD8
    E J; Yan F; Kang Z; Zhu L; Xing J; Yu E
    Hum Immunol; 2018 Jun; 79(6):446-452. PubMed ID: 29544815
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. New Staging System for colorectal cancer Patients with Synchronous Peritoneal Metastasis in Accordance with the Japanese Classification of colorectal Carcinoma: A Multi-Institutional Study.
    Noura S; Ohue M; Ito Y; Miyoshi N; Kobayashi H; Kotake K; Sugihara K
    Dig Surg; 2016; 33(1):66-73. PubMed ID: 26618448
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Expression of FOXP1 and colorectal cancer prognosis.
    De Smedt L; Palmans S; Govaere O; Moisse M; Boeckx B; De Hertogh G; Prenen H; Van Cutsem E; Tejpar S; Tousseyn T; Sagaert X
    Lab Med; 2015; 46(4):299-311. PubMed ID: 26489674
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Is PCI effective in predicting prognosis in the era of oxaliplatin-based chemotherapy in stage IV colorectal cancer with peritoneal dissemination ?].
    Hatano S; Matsuzawa T; Chika N; Tajima Y; Watanabe Y; Fukuchi M; Baba H; Kumagai Y; Ishibashi K; Mochiki E; Ishida H
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1692-4. PubMed ID: 25731298
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Duodenal mucosal risk markers in patients with familial adenomatous polyposis: effects of celecoxib/ursodeoxycholic acid co-treatment and comparison with patient controls.
    van Heumen BW; Roelofs HM; te Morsche RH; Nagengast FM; Peters WH
    Orphanet J Rare Dis; 2013 Nov; 8():181. PubMed ID: 24245549
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical benefit of surgery for stage IV colorectal cancer with synchronous peritoneal metastasis.
    Kobayashi H; Kotake K; Funahashi K; Hase K; Hirata K; Iiai T; Kameoka S; Kanemitsu Y; Maeda K; Murata A; Ohue M; Shirouzu K; Takahashi K; Watanabe T; Yano H; Yatsuoka T; Hashiguchi Y; Sugihara K;
    J Gastroenterol; 2014 Apr; 49(4):646-54. PubMed ID: 23793379
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Outcomes of surgery without HIPEC for synchronous peritoneal metastasis from colorectal cancer: data from a multi-center registry.
    Kobayashi H; Kotake K; Sugihara K
    Int J Clin Oncol; 2014 Feb; 19(1):98-105. PubMed ID: 23239055
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Substrate optimization and clinical validation of reporter peptides for MS-based protease profiling in serum specimens: a new approach for diagnosis of malignant disease.
    Yepes D; Jacob A; Dauber M; Costina V; Hofheinz R; Neumaier M; Findeisen P
    Int J Oncol; 2011 Jul; 39(1):145-54. PubMed ID: 21503574
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer.
    Tosolini M; Kirilovsky A; Mlecnik B; Fredriksen T; Mauger S; Bindea G; Berger A; Bruneval P; Fridman WH; Pagès F; Galon J
    Cancer Res; 2011 Feb; 71(4):1263-71. PubMed ID: 21303976
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Analysis of ovarian metastasis of colorectal cancer--a comparison between ovarian metastasis and peritoneal metastasis without involving ovaries].
    Ishii M; Ishibashi K; Ishiguro T; Kuwabara K; Ohsawa T; Okada N; Miyazaki T; Yokoyama M; Inokuma S; Ishida H
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2257-9. PubMed ID: 20037388
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Factors influencing outcome after surgery for stage IV colorectal cancer.
    Hotokezaka M; Jimi S; Hidaka H; Ikeda T; Uchiyama S; Nakashima S; Tsuchiya K; Chijiiwa K
    Surg Today; 2008; 38(9):784-9. PubMed ID: 18751942
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Glutathione-S-transferase P1, T1 and M1 genetic polymorphisms in neoadjuvant-treated locally advanced gastric cancer: GSTM1-present genotype is associated with better prognosis in completely resected patients.
    Ott K; Lordick F; Becker K; Ulm K; Siewert J; Höfler H; Keller G
    Int J Colorectal Dis; 2008 Aug; 23(8):773-82. PubMed ID: 18443805
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Study on the prognostic factors of colorectal cancer and on suggested model for prediction].
    Liu W; Nie SF; Chen JG; Huang T; He JJ; Liu C
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Jul; 28(7):700-3. PubMed ID: 18069564
    [TBL] [Abstract] [Full Text] [Related]  


    of 2.